CME Stock Analysis — CME Group
Sector: Financials
AI Verdict
CME trades at a premium the numbers don’t fully support, so unless its network moat delivers a surprise in earnings growth, you’re paying up for stability rather than acceleration.
Competitive Moat
CME Group operates the world’s largest derivatives exchange, controlling critical infrastructure for trading futures and options on interest rates, commodities, and equity indexes. Its defensibility comes from network effects and regulatory barriers that make it nearly impossible for new entrants to replicate its liquidity and clearinghouse trust.
Summary
CME’s near-monopoly on US futures trading makes it a bellwether for market volatility and hedging demand.
Where It Stands
CME is down -12.65% over the past year, trades at 19.3x next year’s earnings (vs. the financials median of 14x), and its RSI at 45.8 signals a cooling phase after recent selling.
Key Metrics
- RSI: 45.8 — Neutral
- Trailing P/E: 20.4x
- Forward P/E: 19.3x
- PEG Ratio: 3.33
- Earnings Growth: +0.1%
- Revenue Growth: +0.2%
- Market Cap: $87.1B
- Dividend Yield: 0.02%
- 1-Year Return: -12.65%
- 52-Week High: $329.16
- 52-Week Low: $218.31
Analyst Consensus
12 Buy · 6 Hold · 3 Sell (21 analysts)
Bull Case
You’re paying 19.3x forward earnings for a business expected to grow EPS by 6.1% next year, with a 24.6% revenue growth print showing its platform remains essential.
Bear Case
With a forward P/E 38% above the sector median and a trailing PEG of 3.33, any P/E compression to the financials median would mean a 27% valuation drop from here.
Catalyst to Watch
Watch for quarterly volume and volatility data—sustained spikes in trading activity could quickly validate the premium multiple.